Thank you for visiting the website of the New York State Neurological Society (NYSNS)! You can use the top menu to discover who we are and how to join as well as find resources for neurologists and the most recent updates on our December 14, 2019 Annual Winter Meeting.  Feel free to contact us if you have any questions or want more information!

Some Additional Exhibit Space NOW Available  for Our 12/14/19 Annual Winter Meeting!

Good news!.  Although we HAD sold out exhibit space for our  12/14/19 Annual Winter Meeting, but we have secured a small amount of additional exhibit space.  However that is going fast, so act now.  We still have attendee space —  so take advantage of early bird registration until November 16! See below for details.

NY State Neurological Society Annual Winter Meeting Registration Open  12/14/19!

Join us at the NY State Neurological Society’s Annual Winter Meeting on Saturday, December 14, 2019 in Manhattan at New York City’s Stewart Hotel,  371 7 Avenue at 31 Street right across from Penn Station. Don’t miss crucial updates on Multiple Sclerosis, Neuro-Ophthalmology, ALS, Dementia, Polyneuropathy and so much more.  7 Hours Category One CME Credit!

To register, go to NYSNS Annual Winter Meeting

7:00 a.m. – 8:00 a.m. Registration and Continental Breakfast with Exhibitors
8:00 a.m – 8:15 a.m. Welcome & AAN Updates
8:15 a.m. – 9:15 a.m. Multiple Sclerosis Update: Claire S.  Reily, MD
9:15 a.m. – 9:55 a.m. Great Cases in Neuro-Ophthalmology: Laura Balcer, MD
9:55 a.m. – 10:15 a.m. Coffee Break/Exhibition Hall
10:15 a.m. – 10:55 a.m. Amyloid Polyneuropathy: Janice Wiesman, MD
10:55 a.m. – 11:35 a.m. ALS Update: Matthew Harms, MD
11:35 a.m. – 12:15 p.m. Dementia Update: Kinga Szigeti, MD
12:15 p.m. – 12:20 p.m. Special Presentation
12:20 p.m. – 1:00 p.m. Lunch/Exhibition Hall
1:00 p.m.-1:15 p.m. MLMIC Update on Medicolegal Issues in NYS/Lunch continues
1:15 p.m. – 1:55 p.m Epilepsy Surgery Myths and Facts: Sean Hwang, MD                       1:55 p.m. – 2:35 p.m. DBS in Neurology: Kelly Andrzejewski, DO, PhD                               2:35 p.m. – 3:15 p.m. Advances in Neurocritical Care and Neuroendovascular Surgery:
Fawaz Al–Mufti, MD
3:15 p.m. – 3:35 p.m. Coffee Break/Exhibition Hall
3:35 p.m. – 4:15 p.m. OPMC Issues: Paula M. Breen, MPA

8:15 a.m. to 9:15 a.m. Multiple Sclerosis Update:   Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Integrity Continuing Education, Inc. designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

9:15 a.m. Onward Remaining Sessions:  This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Medical Society of the State of New York (MSSNY) through the joint providership of MLMIC Insurance Company (MLMIC) and the New York State Neurological Society.  MLMIC is accredited by MSSNY to provide continuing medical education for physicians.  MLMIC designates this live activity for a minimum of 6.0 AMA PRA Category 1 Credit(s)TM  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Welcome Our New Board Members


Goel Dzh1YI5X0AEG8Kv


The New York State Neurological Society (NYSNS) welcomes new Board members and officers for 2019.  Doctor Gil I. Wolfe took the gavel as president at the conclusion of the January 5, 2019 meeting.  Moving into other officer positions were Mill Etienne, MD as Vice President/President-Elect, Allan Perel, MD as Treasurer, and Matthew Robbins, MD as Secretary.  Two new Board members have come on as well.  As of January 13, the Society welcomes Sweta Goel, MD and Melissa Rayhill, MD.  (To see all our Board members and their brief bios, go to the Board of Directors tab at the top of the home page.)   We are glad to have Doctor Goel (left) and Doctor Rayhill (right) “aboard.”

NY Neurosociety Meeting

Member Perspective by Gil I. Wolfe, MD, FAAN, NYSNS President

The following is from the January 21, 2019, Capitol Hill Report, American Academy of Neurology (reprinted with permission) 

The New York State Neurological Society (NYSNS) held its annual Winter Meeting on January 5, 2019, in New York City. Attendance at this year’s educational meeting grew significantly from prior years to more than 150 attendees, including some 20 exhibitors, and offered 6.5 hours of CME credit. Topics included therapy updates in multiple sclerosis, epilepsy, headache and stroke. There were also presentations on medical cannabis, telemedicine, and improving quality of life in Parkinson’s disease. The meeting included two workshops offering hands-on experience in headache procedures and vagal nerve stimulation in epilepsy.

Each year, the NYSNS Winter Meeting features the Neurostakes competition between New York-based neurology residency training programs, a trivia contest in the vein of the TV game show Jeopardy. Six teams of mostly senior neurology residents competed this year, with SUNY Stony Brook coming out on top. Mill Etienne, MD, MPH, FAAN, treasurer of the society, served as MC of the competition. Annual Meeting Committee members included Andrew D. Goodman, MD, FAAN, outgoing president of the society, in addition to Charles Esenwa, MD; Mill Etienne, MD, MPH, FAAN; Matthew S. Robbins, MD, FAAN; and Nilay R. Shah, MD. Cheryl Malone, executive director of NYSNS, played a key role in the meeting’s success.

The NYSNS has plans for smaller, regional meetings during the year, with the next Winter Meeting tentatively planned for October 2019. Check the NYSNeurology.com website for future information.

State neurological societies across the country not only fill an educational role for health care providers but are often involved with advocacy efforts at the state level. For instance, the NYSNS has an Advocacy Committee chaired by Allan Perel, MD, FAAN that monitors issues important to neurologists making their rounds in Albany. Supporting the work of state neurological societies is one of the roles of the Government Relations Committee of the AAN.

Thanks to Our Leadership

Gavel is Passed to Doctor Gil Wolfe at at the Annual Winter Meeting

Below new president Gil Wolfe, MD; past president John Ferro, MD; and outgoing president Andrew Goodman, MD.  Doctor Wolfe helped us celebrate Doctors Ferro and Goodman at the Annual Winter Meeting on January 5, 2019.


thanks to our leadership

The  Annual Winter  Meeting =

A Great Success

What a great meeting!   We hope you were able to join us on January 5.  The Board of Directors of NYSNS is already thinking about the next event, so stay tuned.

Our thanks to our speakers:  Fiona Gupta, MD; Fred Lublin, MD; Matthew Robbins, MD; Robert Glover, MD; Mill Etienne, MD; Lazlo Mechtler, MD; Shazia Alam, DO; and Eric Anderson, MD, PhD.  We heard the latest on Parkinson’s, MS, Headache Therapy, Epilepsy, Medical Cannabis, Stroke, and Telemedicine.  The audience was engaged, and everyone enjoyed the program and networking.

It’s not an NYSNS Meeting without the Neurostakes Competition.  This year the Competition was sponsored by Sunovion Pharmaceuticals.  Our intrepid residents from programs at the University of Rochester, Mt. Sinai, SUNY Upstate, Stony Brook, Albany, and  Northwell Health Hofstra all faced off against quizmaster Mill Etienne, MD.   After a close competition, Stony Brook were this year’s champions.  Congratulations to the Stony Brook  Team:  Cara Harth, MD; Kamil Stefanowski, MD; Alexander C. Ou, MD; and Kathryn Cooper, MD. 

Thanks to all the teams pictured below.

neurostakes teams 2019 img_0064


Here’s the winning team from Stony Brook below.

winning team from stonybrook!



Thanks to our exhibitors and CME providers below for helping to make it all possible.


Gold                                                         Sunovion Pharmaceuticals





Catamount Medical Education*

*CME Provider 



Acadia Pharmaceutials

CLS Behring

Sanofi Genzyme

US WorldMeds



 Biotel Heart Caridonet/Lifewatch


NeuroNet GPO



Quest Diagnostics   


Strongbridge BioPharma

GE Health Care: DatSca

Adamas Pharmaceuticals 



Supernus Pharmaceuticals         


Vertical Pharmaceuticals 

Akcea Therapeutics

Ipsen Biopharmaceuticals


See you at the next meeting!


MLMIC Says . . .

For the first time, the July 2019 issue of MLMIC’s Case Review is available here as a podcast (see below).  Now you can listen to an audio version of each case study and its accompanying legal and risk management analysis. The cases in this new issue include:  Gastroenterologist and Hospital Absolved after Disastrous OutcomeAND  Poor Communication Regarding Medical Management Results in Patient Death.   Listen in at MLMIC Podcast

Check Out  MLMIC Case Review

As previously discussed in the Spring 2017 1ssue of Dateline, MLMIC Insurance
Company is increasingly using summary judgment motions to successfully defend
medical professional liability lawsuits commenced against its policyholders, thus
precluding the need for a lengthy and expensive trial The following IS one such case.



MLMIC (NYSNS Endorsed) Earns A+ Rating According to AM Best

AM Best has assigned a Financial Strength Rating of A+ (Superior) and a Long-Term Issuer Credit Rating of “aa-” to MLMIC Insurance Company (MLMIC) (New York, NY). The outlook assigned to these Credit Ratings (ratings) is stable.

The ratings reflect MLMIC’s balance sheet strength, which AM Best categorizes as strongest, as well as its adequate operating performance, limited business profile and appropriate enterprise risk management. The ratings also benefit from the financial support provided by MLMIC’s direct parent company, National Indemnity Company, which is ultimately owned by Berkshire Hathaway Inc. [NYSE: BRK.A and BRK.B].

MLMIC’s risk-adjusted capitalization, as measured by Best’s Capital Adequacy Ratio (BCAR) is categorized as strongest and AM Best expects it to remain at a similar level in prospective years. The balance sheet strength assessment also considers the company’s track record of positive reserves development, as well as good financial flexibility provided by its publicly traded ultimate parent Berkshire Hathaway Inc.

MLMIC has historically generated an adequate level of operating results, supported by modest underwriting profits and moderate investment returns. Underwriting results have consistently benefited from reserve releases on prior accident years. Prospectively, AM Best does not expect any material change in the company’s profitability levels.

MLMIC’s insurance portfolio is concentrated in the medical malpractice line of business. The company underwrites risks only within New York state, which represents one of the nation’s most challenging market environments. However, management has been able to operate successfully through underwriting cycles while maintaining MLMIC’s leading market position within New York. In addition, risk management capabilities have proven appropriate for the risk profile of the company.

MLMIC is the only endorsed medical liability company of the New York State Neurological Society.  To learn more go to https://www.mlmic.com/  


You Tell CMS (Do It by August 12)

Have you tangled with prior authorization problems connected with Medicare Fee For Service (FFS), Medicare Advantage, Medicaid Advantage or Health Insurance Marketplace Plans? The  Regional Office of the Centers for Medicare/Medicaid Services (CMS) would like to hear from you, and soon (deadline August 12, 2019). Please send your experiences and comments concerning pre-authorization procedures and related “hassles” to PatientsoverPaperwork@cms.hhs.gov.   CMS will keep all comments, stories, experiences and recommendations you share anonymous. (Exceptions:  Your “role” (e.g., clinician), your “location” (e.g., state), or the “facility type” (e.g., hospital).)  The information will help to shape policy and educate operational staff, and may become part of internal presentations.  More information on the “Patients Over Paperwork” initiative is available at: Patients Over Paperwork

Federal Legislative Updates

State Legislative Updates


August 1, 2019

The Medical Society of the State of New York reports that the New York State Department of Financial Services (DFS) says New York  will be delaying adoption of its Workers’ Compensation fee schedule changes for the No-Fault Auto system until October 1, 2020.  The delay stems from auto carriers not having the ability to factor in the medical fee increases when making their rate increase request to adjust auto insurance premiums.

June 19, 2019

The State Legislature is currently considering multiple bills that would drastically increase medical liability insurance premiums and decrease patients’ access to essential health care services.  Malpractice payouts in New York State continue to be far out of proportion to the rest of country, and WalletHub has again listed New York as the worst state in the country in which to be a doctor.  Send emails right now!  Go to  Write an Email NOW

June 14, 2019

The New York State Neurological Society is proud to have been part of the coalition that fought for immunizations and a stop to the measles epidemic in New York.   If you have a moment, thank Assemblymember Jeffrey Dinowitz (office number  (518) 455-5965) from the Bronx  and Senator Brad Hoylman (office number  (518)455-2451) from  Manhattan.  They continued a fight in the face of vocal and intimidating opposition.

Cuomo signs ban on nonmedical vaccine exemptions via

May 4, 2019

The Board of Directors of NYSNS has signed on with a number of other medical societies around the State of New York supporting  1) Assembly Bill 2371/Senate Bill 2994 which would clarify that the only permissible exception from New York’s vaccination requirements is for patient medical conditions that would place patients who are immunized at risk for adverse outcome; and 2)  Assembly Bill 3038/Senate Bill 2847 which would significantly reduce the exorbitant pre-authorization barriers experienced by patients and their physicians that get in the way of timely treatment and medication and would help to protect consumers’ access to their prescription drugs.

AAN  Updates


MSSNY  Updates

Workers’ Compensation News

The Medical Society of the State of New York reports that the New York State Department of Financial Services has decided to delay implementation of the recently updated Workers’ Compensation  Medical Fee Schedule until October 1, 2020 for the Auto No-Fault Program. 

Therefore, you will need to keep the Workers’ Compensation Fee Schedule that was effective on June 1, 2012 for billing claims for the treatment of persons injured as the result of auto accidents.

Public comment  can be sent to Camielle.Barclay@dfs.ny.gov   before April 22, 2019.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s